Novus Biologicals introduces new post-translationally modified Survivin antibody

Novus Biologicals just launched a new Survivin Antibody (NBP1-47639) that is made to a synthetic peptide surrounding the acetylated lysine 129 of the human Survivin protein.  It has recently been shown that Survivin acetylation at amino acid 129 affects its interaction with STAT3, determines its interaction with CRM1 and its subsequent subcellular localization (PMID: 20826784).

The new acetylated survivin antibody has been positively validated for use in immunofluorescence, immunohistochemistry and Western blot analysis. By Western blot on TSA treated HeLa cells, a band is seen at approximately 16.5kDa. This Survivin [acetyl 129] antibody reacts with human and has not been tested for cross-reactivity in other species.

Novus provides a wide variety of Survivin antibodies - view the Survivin Antibody list here or browse only post-translationally modified Survivin antibodies here.


For more information on this new Survivin [acetyl K129] Antibody or to inquire about product collaborations, please contact the Novus Product Development Team by calling 303-730-1950 or via e-mail at

Release Date: 
Monday, September 27, 2010 - 06:00